Hyperphosphatemia in end-stage renal disease patients: Pathophysiological consequences

Kidney International, Supplement

Volumn 56, Issue 73, 1999, Pages

  Llach, Francisco ^a  

^a East Orange General Hospital   (United States)

Author keywords

Calcification; Calciphylaxis; End stage renal disease; Hyperparathyroidism; Mortality

Indexed keywords

CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; CALCIUM SENSING RECEPTOR; CELL SURFACE RECEPTOR;

ARTICLE; CALCINOSIS; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; DETERIORATION; DRUG COMPETITION; HUMAN; HYPERPHOSPHATEMIA; METABOLIC INHIBITION; MORTALITY; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY HYPERPARATHYROIDISM; SOFT TISSUE CALCIFICATION; VITAMIN D METABOLISM; ANIMAL; BLOOD; HYPERPARATHYROIDISM; PHYSIOLOGY; REVIEW;

ANIMALS; CALCINOSIS; CALCIPHYLAXIS; CALCITRIOL; HUMANS; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; PHOSPHATES; RECEPTORS, CALCIUM-SENSING; RECEPTORS, CELL SURFACE;

EID: 0033390881     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.07316.x     Document Type: Article

References (47)

1. BLOCK GA, HULBERT-SHEARON TE, LEVIN NW, JONES RT: Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31:607-617, 1998
2. LOPEZ-HILKER D, DUSSO AS, RAPP NS, MARTIN KJ, SLATOPOLSKY E: Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J Physiol 259:F432-F437, 1990
3. APARICIO M, COMBE C, LAFAGE MH, DUVAL A: In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol. Nephron 63:122-123, 1993
4. LUCAS PA, BROWN RC, WOODHEAD JS, COLES G: 1,25 dihydroxycholecalciferol and parathyroid hormone in advanced renal failure: Effects of simultaneous protein and phosphorus restriction. Clin Nephrol 25:7-19, 1986
5. TESSITORE N, VENTURI A, ADMAI S, RONCARI C, RUGIU C, CORGNATI A, BONUCCI E, MASCHIO G: Relationship between serum vitamin D metabolites and dietary intake of phosphate in patients with early renal failure. Miner Electrolyte Metab 13:38-44, 1987
6. FINE A, COX D, FONTAINE B: Elevation of serum phosphate affects parathyroid hormone levels in only 50% of hcmodialysis patients, which is unrelated to changes in serum calcium. J Am Soc Nephrol 3:1947-1953, 1993
7. KILAV R, SILVER J, NAVEH-MANY T: Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 96:327-333, 1995
8. NAVEH-MANY T, RAHAMIMOV R, LIVNI N, SILVER J: Parathyroid cell proliferation in normal and chronic renal failure rats: the effects of calcium, phosphate and vitamin D. J Clin Invest 96:1786-1793, 1995
9. YI H, FUKAGAWA M, YAMATO H, KUMAGAI M, WATANABE T, KUROKAWA K: Prevention of enhanced parathyroid hormone secretion synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus. Nephron 70:242-248, 1995
10. HERNANDEZ A, CONCEPCION MT, RODRIGUEZ M, SALIDO E, TORRES A: High phosphorus diet increases preproPTH mRNA independent of calcium and calcitriol in normal rats. Kidney Int 50:1872-1878, 1996
11. ALMADEN Y, CANALEJO A, HERNANDEZ A, BALLESTEROS E, CARCIA-NAVARRO S, TORRES A, RODRIGUEZ M: Direct effect of phosphorus on parathyroid hormone secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 11:970-976, 1996
12. SLATOPOLSKY E, FINCH J, DENDA M, RITTER C, ZHONG A, DUSSO A, MACDONALD P, BROWS AJ: Phosphate restriction prevents parathyroid cell growth in uremic rats. High phosphate directly stimulates PTH secretion in vitro. J Clin Invest 97:2534-2540, 1996
13. NIELSEN PK, FELDT-RASMUSEN U, OLGAARD K: A direct effect of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 11:1762-1768, 1996
14. BRAUN J, OLDENDORF M, MOSHAGE W, HEIDLER R, ZEITLER E, LUFT FC: Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 27:394-401, 1996
15. KUZELA DC, HUFFER WE, CONGER JD, WINTER SD, HAMMOND WS: Soft tissue calcification in chronic dialysis patients. Am J Pathol 86:403-424, 1977
16. RIBEIRO S, RAMOS A, BRANDAO A, REBELO JR, GUERRA A, RESINA C, VILALOBOS A, CARVALHO F, REMEDIO F, RIBEIRO F: Cardiac valve calcification in haemodialysis patients: role of Ca-phosphate metabolism. Nephrol Dial Transplant 13:2037-2040, 1998
17. TERMAN DS, ALFREY AC, HAMMOND WS, DONNDELINGER T, OGDEN DA, HOLMES JH: Cardiac calcification in uremia. A clinical, biochemical and pathologic study. Am J Med 50:744-755, 1971
18. FORMAN MB, VIRMASI R, ROBERTSON RM, STONE WJ: Mitral anular calcification in chronic renal failure. Chest 85:367-371, 1984
19. ROSTAND SG, SANDERS C, KIRK KA, RUTSKY EA, FRASER RG: Myocardial calcification and cardiac dysfunction in chronic renal failure. Am J Med 85:651-657, 1988
20. MAHER ER, YOUNG G, SMYTH-WALSH B, PUGH S, CURTIS JR: Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 2:875-877, 1987
21. STRAUMANN E, MEYER B, MISTELI M, BLUMBERG A, JENZER HR: Aortic and mitral valve disease in patients with end stage renal failure on long-term haemodialysis. Br Heart J 67:236-239, 1992
22. MILLINER DS, ZINSMEISTER AR, LIEBERMAN E, LANDING B: Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38:931-936, 1990
23. HÜTING J: Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis. Chest 105:383-388, 1994
24. THOMPSON GR, NAOUMOVA R, SIDHU P, UNDERWOOD R: Predicting coronary heart disease. Lancet 343:670-671, 1994
25. JING J, KAWASHIMA A, SICKLER K, RAVAL BK, OLDHAM SA: Metastatic cardiac calcification in a patient with chronic renal failure who was undergoing hemodialysis: radiographic and CT findings. Am J Roentgenol 170:903-905, 1998
26. WADE MR, CHEN YJ, SOLIMAN M, KAPTEIN E, MASSRY SG, RAHIMTOOLA SH, CHANDRARATNA PA: Myocardial texture and cardiac calcification in uremia. Miner Electrolyte Metab 19:21-24, 1993
27. LLACH F: Calcific uremic arteriolopathy (calciphylaxis): an evolving entity? (Editorial) Am J Kidney Dis 32:514-518, 1998
28. BURKE SK, SLATOPOLSKY EA, GOLDBERG DI: RenaGel, a novel Ca-and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteers. Nephrol Dial Transplant 12:1640-1644, 1997
29. CHERTOW GM, BURKE SK, LAZARUS JM, STENZEL KH, WOMBOLT D, GOLDBERG D, BONVENTRE JV, SLATOPOLSKY E: Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. Am J Kidney Dis 29:66-71, 1997
30. SELYE H: Calciphylaxis. Chicago, University of Chicago Press, 1962
31. ANDERSON DC, STEWART WK, PIERCY DM: Calcifying panniculitis with fat and skin necrosis in a case of uremia with autonomous hyperparathyroidism. Lancet 2:323-325, 1968
32. GIPSTEIN RM, COBURN JW, ADAMS DA, MASSRY SG: Calciphylaxis in man. Arch Intern Med 136:1273-1280, 1976
33. ANDROGUE HJ, FRAZIER MR, ZELUFF B, SUKI WN: Systemic calciphylaxis revisited. Am J Nephrol 1:177-183, 1981
34. KATZ AL, HAMPERS CL, MERRILL JP: Secondary hyperparathyriodism and renal osteodystrophy in chronic renal failure: analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy. Medicine 48:333-374, 1969
35. MASSRY SG, COBURN JW, HARTENBOWER DL, SHINABERGER JH, DEPALMA JR, CHAPMAN E, KLEEMAN CR: Mineral content of human skin in uremia. Effect of secondary hyperparathyroidism and hemodialysis. Proc Eur Dial Transplant Assoc 7:146-148, 1970
36. MASSRY SG, COBURN JW, HARTENBOWER DL, SHINABERGER JH, DE PALMA JR, CHAPMAN E, KLEEMAN CR: The effect of calcemic disorders and uremia or the mineral content of the skin. Israel J Med Soc 7:514-517, 1971
37. CAMPISTOL JM, ALMIRALL J, MARTIN E, TORRAS A, REVERT L: Calcium-carbonate-induced calciphylaxis. Nephrol 51:549-550, 1989
38. COATES T, KIRKLAND GS, DYMOCK RB, MURPHY BF, BREALEY JK, MATHEW TH, DISNEY APS: Ischemic tissue necrosis (calciphylaxis) in renal failure. Am J Kidney Dis 32:384-391, 1998
39. BLEYER AJ, CHOI M, IGWEMEZIE B, DE LA TORE E, WHITE WL: A case control study of proximal calciphylaxis. Am J Kidney Dis 32:376-383, 1998
40. HANDA SP, SOHI PS: Proximal calciphylaxis in four insulin requiring diabetic hemodialysis patients. Am J Kidney Dis 29:812, 1997
41. RODRIGUEZ M, FELSENFELD AJ, DUNLAY R et al: The effect of long-term calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 2:1014-1019, 1991
42. QUARLES LD, YOHAY DA, CARROLL BA, SPRITZER CE, MINDA SA, BARTHOLOMAY D, LOBAUGH BA: Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710-1721, 1994
43. WANG Q, PALNITKAR S, PARFITT AM: Parathyroid cell proliferation in the rat: effect of age and of phosphate administration and recovery. Endrocrinology 21:4558-4562, 1996
44. FUKUDA N, TANAKA H, TOMINAGA Y, FUKAGAWA M, KUROKAWA K, SEINO Y: Decreased 1,25 Dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic iremic patients. J Clin Invest 92:1436-1443, 1993
45. KORKOR AB: Reduced binding of 3(H)1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure. N Engl J Med 316:1573-1577, 1987
46. BROWN EM, POLLACK M, HEBERT SC: The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 49:15-29, 1998
47. BROWN AJ, RITTER C, FINEH J, SLATOPOLSKY E: Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate. Kidney Int 55:1284-1292, 1999